Objective: The subintimal arterial flossing with antegrade-retrograde intervention technique has been used to overcome antegrade recanalization failures for peripheral lower limb arterial occlusive disease. There are few outcomes published for this technique and we sought to evaluate outcomes at our institution over a 7-year period.
Endovascular techniques are common practice in treating patients with chronic critical limb ischemia. Since subintimal recanalization was initially described by Bolia et al, treatment of long superficial femoral artery 1 and tibial artery occlusions 2 are common. Many interventionalists have been successful in treating patients using subintimal angioplasty via an antegrade approach as demonstrated in a metaanalysis done by Bown et al. 3 It demonstrated a technical success rate of 86% with a limb salvage rate of 89%. However, the technical success of the procedure is still restricted by the failure in some cases to cross the lesion and reenter the true lumen. Since being described by Spinosa et al 4 in 2005, the subintimal arterial flossing with antegrade-retrograde intervention (SAFARI) technique has been used to overcome antegrade recanalization failures. Retrograde access is obtained and a guidewire is passed cephalad from the popliteal artery, posterior tibial artery, or dorsalis pedis artery, until it reaches the subintimal space created from the antegrade approach. Since this initial study, there has been limited published studies on the outcomes of the SAFARI technique. [5] [6] [7] [8] [9] Given this relative paucity of studies, we retrospectively evaluated patients who had undergone the SAFARI procedure at our institution to assess outcomes and factors that my influence them.
METHODS
Patients. All patients provided informed consent before any intervention. Institutional ethics board approval was obtained for this study. A retrospective study of SAFARI procedures from January 2009 to June 2016 was carried out. The hospital electronic patient database, along with the Vascular Quality Initiative, a vascular surgery database, was retrospectively accessed and patients were included if they had undergone SAFARI procedures within the last 7 years. All patients were treated by an interventional radiologist and/or a vascular surgeon experienced in subintimal recanalization and endovascular interventions as the primary operator with trainees providing assistance during the procedures. Patients were selected to undergo the SAFARI procedure if the antegrade attempt failed, the patients were not candidates for surgical intervention, and there was an available artery for retrograde access.
Procedural technique. The antegrade procedure was initially attempted in all patients in a manner similar to that defined by Bolia et al, 10 with some variation in devices used including the use of reentry devices. Once reentry into the distal true lumen was unsuccessful via an antegrade approach, access to the true lumen was attempted via a retrograde approach. This was done by directly entering the ipsilateral posterior tibial, popliteal or dorsalis pedal artery with fluoroscopic or ultrasound guidance. Once retrograde entry was achieved, therapeutic anticoagulation, if not already administered with the antegrade approach, was administered using intravenous heparin; a 0.014-or a 0.018-inch guidewire was initially advanced followed by a 2.4-F support catheter. In a majority of the cases, the guidewire could be advanced into the true lumen or subintimal lumen created by the antegrade catheter and past the level of occlusion without much difficulty. After this step, the wire was engaged with a snare and pulled through the antegrade access creating a flossing-type guidewire. Once this through-and-through access was created, the occlusion was dilated/stented from the antegrade direction. When the true lumen could not be reentered from either direction, a subintimal entry technique was performed where balloons were advanced from each direction and inflated simultaneously adjacent to but not overlapping within the subintimal space. 11 This maneuver often resulted in access to the true lumen. Once the occlusion was angioplastied and/or stented, the catheter was removed and posterior tibial, popliteal, or dorsalis pedis puncture site hemostasis was obtained with manual compression. Femoral access site hemostasis was obtained either with a femoral arterial closure device or manual compression. No additional independent procedures were performed for initial revascularization in the study population. Antiplatelet medications were not withheld before the intervention and were continued after the intervention.
Study endpoints and definitions. Every patient was assessed for age, existing comorbidities, symptoms, prescription medication, and atherosclerotic risk factors. A number of procedural variables were also collected, including vessels accessed, total procedure time and radiation dose. Primary vs primary assisted patency, limb salvage, and time to death were also examined. Primary patency was defined as patent limb segments (>50% reduction in luminal diameter determined by a peak systolic velocity ratio of $2.5) without recurrent stenosis or occlusion vs primary assisted patency (reintervention for stenosis or occlusion in the treated leg). Occlusion was defined as no flow in the treated vessel by ultrasound or angiography. Kaplan-Meier curves with 95% confidence intervals were generated for primary vs primaryassisted patency, patient survival, and limb salvage. Procedure time was defined as the time the patient was in the procedure room from prepping of the access site to hemostasis being obtained. A person-year analysis was performed that allows the creation of an incidence rate when individuals contributed differing amounts of time under observation. Attempts were made to follow-up all patients at different time points after the procedure with duplex ultrasound scans. The follow-up was random according the ordering vascular surgeon and did not follow any specific algorithm. Forty-two patients had follow-up duplex scans with no fixed interval with most undergoing a duplex study within a month of the intervention. All calculations were performed with SPSS v 24.0 (SPSS, Inc, Chicago, Ill).
RESULTS
All 52 patients (35 men, 17 women) underwent SAFARI technique over the course of this retrospective study after attempting antegrade crossing of the occlusion. A large proportion of the patient group (63.5%) had diabetes, more than one-half of patients had a previously documented myocardial infarction (53.8%), and more than one-third of patients had end-stage renal disease (36.5%). There were 26 patients (49.1%) with a previous antegrade attempt; 50.9% of patients had no previous procedure. Most lesions (88.5%) treated were classified as TransAtlantic Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC) II class C or D (Table I) .
ARTICLE HIGHLIGHTS
The most common artery that was accessed distally was the anterior tibial artery in 29 cases (55.8%), of which the dorsalis pedis artery was accessed in 12 of the 29 cases and the posterior tibial artery which was accessed in 21 cases (40.4%). The distal superficial femoral artery and the popliteal artery were only punctured once each respectively (Table II) . Of all the cases included in this study, 15 patients (28.8%) had arteries that were stented. All of these stents were self-expanding stents, which included the Supera stent (Abbott, Abbott Park, Ill), the Zilver stent (Cook, Bloomington, Ind), the EPIC SFA stent (Boston Scientific, Natick, Mass), the Protégé EverFlex stent (Medtronic, Minneapolis, Minn), and the Innova stent. No drug-eluting or covered stents were placed.
Based on procedural devices used/implanted, clopidogrel was prescribed in 15 cases after the procedure, heparin was prescribed in 5 cases, and there were 6 cases in which clopidogrel and heparin were prescribed after the operation in addition to preprocedure aspirin. Additionally, warfarin was prescribed in four patients after the conclusion of the SAFARI; the remaining 22 subjects had no additional antiplatelet agents prescribed after the procedure.
Technical success, as defined by the ability to successfully recanalize the lumen using SAFARI techniques, was achieved in 33 cases (63.5%). For the remaining cases, failure was owing to an inability to traverse the segmental occlusion despite distal reconstitution. There was an infrageniculate occlusion of a single artery in 20 cases (39.2%), 2 arteries in 25 cases (49.0%), and 3 arteries in 6 cases (11.8%). The mean procedure time was 197.12 6 61.36 minutes, with a mean fluoroscopy time of 40.87 6 18.27 minutes. In terms of clinical success, patients, on average, improved from a preprocedural ankle-brachial index (ABI) score of 0.54 6 0.25 to a postprocedural ABI score of 0.77 6 0.25. ABIs were available in 78% of patients (26/33) with the remaining not obtainable owing to calcified vessels preventing proper measurement. Incompressible arteries also possibly skewed obtained ABI scores. There was one case where SAFARI was attempted but almost immediately stopped owing to failure to pass the wire from the anterior tibial artery into the distal superficial femoral artery, even after several attempts. Thus, it was decided to abandon the procedure.
At follow-up, patients were recorded as having primary patency, primary-assisted patency, or occlusion. Demographics were compiled on preoperative factors for these three groups (Table III) (Fig 2) , with an average survival time of 6.0 months (SE ¼ 0.92). Our primary patency rate at 3 and 6 months were 65% and 60%, respectively, for technically successful cases. However, only 20 patients had available follow-up information with follow-up times ranging from a few days to 10 months. The rest of the patients were lost to follow-up and no secondary patency was achieved in any patient.
Time to amputation was also investigated with a quarter of all patients (n ¼ 13) required later amputation during follow-up and the incidence was found to be 3.4 cases per-person year (Fig 3) . Six amputations were digital, one was transmetatarsal, one was a below-the-knee amputation, and another was an above-the-knee amputation in patients that had a successful SAFARI procedure. Four patients had -the-knee amputations after an unsuccessful SAFARI procedure. The limb salvage rate at the mean follow-up time of 5.44 months (SE ¼ 0.94) was 78.8%. Furthermore, 6 patients died during followup with an average of 0.38 deaths per person-year. The mortality rate in our patient cohort was 11.5% (6/52) with death ranging from 0 to 21 months after surgery.
Five patients had complications with three of the patients having small to moderate size groin hematomas that were managed conservatively and one patient had limited retroperitoneal bleeding that was managed conservatively with fluids. One patient developed bleeding into the peritoneal space that communicated with a postoperative hernia not evident on ultrasound imaging that overlay the common femoral artery puncture identified at the time of exploratory laparotomy and surgical repair. The patient died 2 days later owing to unmanageable coagulopathy with ongoing bleeding. During clinical follow-up, there were no observed radiation exposure complications (erythema, dyspigmentation, or dermal atrophy).
DISCUSSION
In our study, the SAFARI procedure is a relatively safe and effective technique for the high-risk patient population who has failed antegrade recanalization. Similar to studies done previously in high-risk patient groups, 12, 13 our study has displayed similar outcomes, but in a larger population group.
When looking initially at our technical success rate of 63.5%, it is much lower when compared with earlier studies. In the study done by Rogers et al, 14 they reported technical success rate of 85%, similar to a study done by Montero-Baker et al, 15 in which they described a technical success rate of 86%. Additionally, in a larger study, Walker 16 reported a technical success rate of 93%.
However, this observed inconsistency may because our patient population had a significant number of comorbidities, including a large portion of our cohort who were classified as either TASC II C or D. Our technical success rate is more consistent with the studies done by Bazan et al 12 and El-Sayed et al, 13 in which they reported a technical success rate of 69% and 67% respectively. Their patient populations were similar to our patient group. The patients in our study only had the SAFARI procedure performed if they had failed the conventional antegrade approach to recanalization, perhaps suggesting that this was a more complex and considerably diseased patient cohort. Another factor that might suggest that our population was potentially a more complex patient cohort is the differences in procedure time. Hua et al 5 reported a mean operating time of 140.1 6 28.4 minutes with popliteal access and 127.6 6 28.4 minutes with posterior tibial or dorsal pedalis access after surgical exposure in their patient cohorts respectively. Our operating time of 197.1 6 61.4 minutes is considerably higher than the SAFARI study done by Hua et al, suggesting that our patient group had more complicated lesions. However, this study did not define procedure time. Additionally, we treated more patients with renal failure, who often have very calcified vessels, than the previous study mentioned, suggesting that this could be a contributing factor to the longer procedure time.
Our primary patency rates of 65% and 60% at 3 and 6 months, respectively, are relatively similar to the results found in much larger studies that assessed outcomes of subintimal recanalization performed only from an antegrade approach. In a literature review done by Brennan, 17 in which he examined four studies and 584 limbs, he found that the mean estimate for 12-month primary patency rate was 55.8% (95% confidence interval, 51.9%-60%). A systematic review was also conducted by Met et al, 18 in which they looked at antegrade subintimal angioplasty in 23 different studies with a total of 1549 patients and found that, on average, the primary patency rate at 1 year was around 50%. Although we do not have a primary patency rate for follow-up at 12 months, our results at 3 and 6 months are similar to these studies. 12 and El-Sayed et al. 13 They reported mortality rates of 23% and 28%, respectively, whereas our patient group had a mortality rate of 11.5%. It is important to note, however, that at least one death was attributable to the procedure directly, whereas there was none reported in either of the two previously mentioned studies. Nonetheless, the deaths are probably more attributable to the fact that this procedure was done in a higher risk patient population. When comparing preoperative variables, a significant difference in patients with diabetes was noted in the primary assisted patency group vs the occlusion group. This finding may reflect a difference in survival within diabetic patients or a selection bias for intervention and/or followup in these patients. Given our small retrospective sample size, the explanation for this finding could not be determined.
There are some aspects of the SAFARI procedure that interventionalists need to consider. First, there is doubt surrounding retrograde access from the tibial vessels in the foot owing to their small size. Furthermore, there is a fear of severe complications at the vessel access site owing to possible perforation or thrombosis. It is important to note that, in our study, although there were some minor complications related to the antegrade access site, with the use of ultrasound or fluoroscopy guidance, there were no complications related to the pedal access site, suggesting that retrograde access is safe to perform. This finding is comparable with what has been reported by Bazan et al 12 and El-Sayed et al, 13 who demonstrated no pedal access complications with the use of ultrasound guidance. There are several limitations to this study that should prompt further research. Because of this study's retrospective nature at one institution with patients who are not randomized, there is the potential for bias in this group. An additional bias was that we were not able to ascertain how many patients that had a failed antegrade approach that did not proceed to a SAFARI procedure and for what reasons. The number of patients in this study is also too small to make any significant conclusion with regard to the use of SAFARI in a high-risk population. The follow-up times were poor and inconsistent between different patients, and that factor may have an effect on the results. Unfortunately, the patient population was elderly, immobile, with multiple comorbidities and from an extensive geographical area, highlighting the challenge of follow-up this population. Additionally, there was no comparison with a similar group of patients who had undergone an antegrade procedure and there were multiple treating physicians.
CONCLUSIONS
This study demonstrates use of SAFARI or retrograde pedal access has moderate technical success when antegrade attempts have failed for limb threatening ischemia with acceptable limb salvage rates out to six months. This technique expands revascularization options after failed conventional endovascular antegrade approaches.
